Formulation and characterization of orodispersible tablet of glimepiride
The present study is regarding, Glimepiride is one derivatives of sulfonyl urea used in the treatment of Type II DM which classified as class-II (BCS) of high permeability and low degree of solubility. The endeavor is to improve its solubility by solvent vaporization method to enhance the rate of di...
Saved in:
Main Authors: | Ahmad AB Yosef Kinani (Author), Hassanien Sagban Taghi (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erratum: Formulation and characterization of orodispersible tablet of glimepiride
Published: (2023) -
Characterization of orodispersible tablets and orodispersible films
by: Drašković Milica, et al.
Published: (2018) -
Formulation and evaluation of fast disintegrating tablet of glimepiride
by: Arooj Khalid, et al.
Published: (2018) -
Formulation and evaluation of buccal bioadhesive tablets using glimepiride as a model drug
by: Syeda Sualyha Noor, et al.
Published: (2021) -
The Influence of the Intergranular Superdisintegrant Performance on New Drotaverine Orodispersible Tablet Formulations
by: Robert-Alexandru Vlad, et al.
Published: (2023)